Altimmune, Inc. - Common stock, par value $0.0001 per share (ALT)

CUSIP: 02155H200

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
129,919,091
Total 13F shares
41,476,255
Share change
+3,833,788
Total reported value
$156,373,200
Put/Call ratio
73%
Price per share
$3.77
Number of holders
157
Value change
+$14,303,174
Number of buys
77
Number of sells
90

Security key

02155H200

Report period

Q3 2025

Institutions

157

Top holders

10

Top shareholders of ALT - Altimmune, Inc. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F 13D/G
Company
7.6%
from 13D/G
6,372,560
$24,661,807 30 Jun 2025
VANGUARD GROUP INC
13F
Company
4%
5,167,124
$19,996,771 30 Jun 2025
13F
STATE STREET CORP
13F
Company
2.1%
2,753,638
$10,656,579 30 Jun 2025
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
2.1%
2,750,000
$10,642,500 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.5%
1,934,880
$7,489,412 30 Jun 2025
13F
AMERIPRISE FINANCIAL INC
13D/G 13F
Company
1.9%
1,443,932
$7,306,296 -$19,283,488 31 Mar 2025
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
1.2%
1,619,747
$6,268,421 30 Jun 2025
13F
Knoll Capital Management, LLC
13F
Company
0.86%
1,121,524
$4,340,297 30 Jun 2025
13F
Caption Management, LLC
13F
Company
0.75%
980,781
$3,795,622 30 Jun 2025
13F
FEDERATED HERMES, INC.
13F
Company
0.7%
915,458
$3,542,823 30 Jun 2025
13F
UBS Group AG
13F
Company
0.68%
886,918
$3,432,373 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.64%
835,407
$3,233,025 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.55%
716,019
$2,770,994 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.49%
640,346
$2,478,139 30 Jun 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.4%
523,461
$2,025,794 30 Jun 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.38%
499,238
$1,932,052 30 Jun 2025
13F
GROUP ONE TRADING LLC
13F
Company
0.36%
469,389
$1,816,535 30 Jun 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.34%
447,470
$1,730,422 30 Jun 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.34%
437,286
$1,692,297 30 Jun 2025
13F
FMR LLC
13F
Company
0.31%
401,843
$1,555,133 30 Jun 2025
13F
Beirne Wealth Consulting Services, LLC
13F
Company
0.26%
342,458
$1,325,313 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.26%
332,016
$1,284,900 30 Jun 2025
13F
BARCLAYS PLC
13F
Company
0.22%
292,095
$1,130,407 30 Jun 2025
13F
Virtu Financial LLC
13F
Company
0.21%
267,778
$1,036,000 30 Jun 2025
13F
Scientech Research LLC
13F
Company
0.2%
254,312
$984,187 30 Jun 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.19%
251,866
$974,722 30 Jun 2025
13F
Caitong International Asset Management Co., Ltd
13F
Company
0.18%
239,630
$927,368 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.18%
233,506
$903,668 30 Jun 2025
13F
BROWN WEALTH MANAGEMENT, LLC
13F
Company
0.18%
231,083
$894,291 30 Jun 2025
13F
Steward Partners Investment Advisory, LLC
13F
Company
0.16%
213,384
$825,797 30 Jun 2025
13F
GERBER, LLC
13F
Company
0.16%
206,778
$800,231 30 Jun 2025
13F
Nuveen, LLC
13F
Company
0.16%
202,355
$783,114 30 Jun 2025
13F
Hennion & Walsh Asset Management, Inc.
13F
Company
0.15%
188,955
$731,256 30 Jun 2025
13F
IMC-Chicago, LLC
13F
Company
0.14%
186,818
$722,986 30 Jun 2025
13F
EXCHANGE TRADED CONCEPTS, LLC
13F
Company
0.14%
175,707
$679,986 30 Jun 2025
13F
MOODY ALDRICH PARTNERS LLC
13F
Company
0.12%
157,614
$609,966 30 Jun 2025
13F
Sculptor Capital LP
13F
Company
0.12%
151,000
$584,370 30 Jun 2025
13F
INTECH INVESTMENT MANAGEMENT LLC
13F
Company
0.11%
144,890
$560,724 30 Jun 2025
13F
Woodline Partners LP
13F
Company
0.11%
142,863
$552,880 30 Jun 2025
13F
Brevan Howard Capital Management LP
13F
Company
0.1%
133,209
$515,519 30 Jun 2025
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.1%
129,200
$500,004 30 Jun 2025
13F
Summit Financial Wealth Advisors, LLC
13F
Company
0.09%
122,988
$475,964 30 Jun 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.09%
121,364
$470,000 30 Jun 2025
13F
Richard I. Eisenstadt
3/4/5
Chief Financial Officer
mixed-class rows
236,037
mixed-class rows
$441,118 30 Jan 2024
RHUMBLINE ADVISERS
13F
Company
0.09%
113,981
$441,097 30 Jun 2025
13F
Invesco Ltd.
13F
Company
0.08%
106,863
$413,560 30 Jun 2025
13F
Avidity Partners Management LP
13F
Company
0.08%
105,000
$406,350 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.08%
104,697
$405,178 30 Jun 2025
13F
SILVERCREST ASSET MANAGEMENT GROUP LLC
13F
Company
0.08%
103,500
$400,545 30 Jun 2025
13F
Rafferty Asset Management, LLC
13F
Company
0.08%
102,011
$394,783 30 Jun 2025
13F

Institutional Holders of Altimmune, Inc. - Common stock, par value $0.0001 per share (ALT) as of Q3 2025

As of 30 Sep 2025, Altimmune, Inc. - Common stock, par value $0.0001 per share (ALT) was held by 157 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,476,255 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, TANG CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, MORGAN STANLEY, TWO SIGMA ADVISERS, LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and CITADEL ADVISORS LLC. This page lists 157 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
179
Q3 2025 holders
157
Holder diff
-22
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .